Band 3 and glycophorin are progressively aggregated in density-fractionated sickle and normal red blood cells. Evidence from rotational and lateral mobility studies.
Band 3 aggregation in the plane of the red blood cell (RBC) membrane is postulated to be important in the pathophysiology of hemolysis of dense sickle and normal RBCs. We used the fluorescence photobleaching recovery and polarized fluorescence depletion techniques to measure the lateral and rotational mobility of band 3, glycophorins, and phospholipid analogues in membranes of density-separated intact RBCs from seven patients with sickle cell disease and eight normal controls. The fractions of laterally mobile band 3 and glycophorin decreased progressively as sickle RBC density increased. Normal RBCs also showed a progressive decrease in band 3 fractional mobility with increasing buoyant density. Rapidly rotating, slowly rotating, and rotationally immobile forms of band 3 were observed in both sickle and normal RBC membranes. The fraction of rapidly rotating band 3 progressively decreased and the fraction of rotationally immobile band 3 progressively increased with increasing sickle RBC density. Changes in the fraction of rotationally immobile band 3 were not reversible upon hypotonic swelling of dense sickle RBCs, and normal RBCs osmotically shrunken in sucrose buffers failed to manifest band 3 immobilization at median cell hemoglobin concentration values characteristic of dense sickle RBCs. We conclude that dense sickle and normal RBCs acquire irreversible membrane abnormalities that cause transmembrane protein immobilization and band 3 aggregation. Band 3 aggregates could serve as cell surface sites of autologous antibody binding and thereby lead to removal of dense sickle and normal (senescent) RBCs from the circulation.
Corbett
J D
JD
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Golan
D E
DE
D000755:Anemia, Sickle Cell / Q000097:blood*; D001457:Anion Exchange Protein 1, Erythrocyte / Q000502:physiology*; D002469:Cell Separation; D002501:Centrifugation, Zonal; D004903:Erythrocyte Aggregation; D004910:Erythrocyte Membrane / Q000502:physiology*; D004912:Erythrocytes / Q000502:physiology*; D005454:Fluorescence Polarization / Q000295:instrumentation / Q000379:methods; D006021:Glycophorins / Q000502:physiology*; D006801:Humans; D008563:Membrane Lipids / Q000097:blood*; D010743:Phospholipids / Q000097:blood*; D012016:Reference Values
D001457:Anion Exchange Protein 1, Erythrocyte; D006021:Glycophorins; D008563:Membrane Lipids; D010743:Phospholipids